HHS Secretary Kennedy Moves to Allow Six Unproven Peptides Under Enforcement Discretion

Health Secretary Robert F. Kennedy Jr. has reportedly granted access to six peptides that have not been approved by the FDA. The substances, which have gained popularity among supporters of the MAHA movement, are now covered by an enforcement discretion policy. Critics note that the decision effectively overrules the FDA's regulatory process. Ars Technica reports that peptide sellers have welcomed the change. The source article provides limited detail beyond these points, so further specifics about the peptides or the policy's scope are not covered here.